Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PI4KA | P42356 | 10/20 | 0.59 |
| ▸ | PI4K2B | Q8TCG2 | 10/20 | 0.59 |
| ▸ | PI4K2A | Q9BTU6 | 10/20 | 0.59 |
| ▸ | PI4KB | Q9UBF8 | 10/20 | 0.59 |
| ▸ | EGFR | P00533 | 2/20 | 0.59 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | CA4 | P22748 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | AHCY | P23526 | 1/20 | 0.48 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.46 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | GSK3B | P49841 | 1/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25882848 | 0.83 | PI4KA (0.55) | PI4KAPI4K2BPI4K2API4KBEGFR | |
| SCHEMBL5111652 | 0.81 | PI4KA (0.47) | PI4KAPI4K2BPI4K2API4KBEGFR | |
| SCHEMBL25312468 | 0.81 | MKNK2 (0.46) | EGFRCA1CA2CA4CA9 | |
| SCHEMBL25883906 | 0.80 | KLKB1 (0.50) | PI4KAPI4K2BPI4K2API4KBEGFR | |
| SCHEMBL25883871 | 0.79 | PI4KA (0.49) | PI4KAPI4K2BPI4K2API4KBEGFR | |
| SCHEMBL25883894 | 0.79 | PI4KA (0.49) | PI4KAPI4K2BPI4K2API4KBEGFR | |
| SCHEMBL25884967 | 0.79 | PI4KA (0.49) | PI4KAPI4K2BPI4K2API4KBEGFR | |
| SCHEMBL25884953 | 0.79 | PI4KA (0.49) | PI4KAPI4K2BPI4K2API4KBEGFR | |
| SCHEMBL25310770 | 0.79 | PI4KA (0.68) | PI4KAPI4K2BPI4K2API4KBEGFR | |
| SCHEMBL26583128 | 0.79 | PI4KA (0.48) | PI4KAPI4K2BPI4K2API4KBEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331707-A1 | PROGRAMMED CELL NECROSIS INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) | 2023-10-19 | — | — | US | disclosed |
| EP-4215532-A1 | PROGRAMMED CELL NECROSIS INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences (CN) | 2023-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331707-A1 | PROGRAMMED CELL NECROSIS INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF | RIPK1, RIPK4, RIPK3 | PI4KA 628/4885PI4K2B 1222/4885PI4K2A 1234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.